TECH
What one share of BIO-TECHNE holds
Biological Products, (No Diagnostic Substances)
Bio-Techne and its subsidiaries, collectively doing business as Bio-Techne Corporation (“Bio-Techne”, “we”, “our”, “us” or the “Company”), develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide.
BIO-TECHNE’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $7.74 |
|---|---|
| Profit | $1.16 |
| Capex (buildings and equipment) | $0.18 |
| Free cash flow | $1.68 |
| Dividends | $0.32 |
| Cash and investments | $1.70 |
| Debt | $1.28 |
| Book value | $13.51 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $3.75 | $0.51 | $0.10 | $0.86 | $0.32 | $6.36 |
| 2018 | $4.22 | $0.83 | $0.14 | $0.98 | $0.32 | $7.17 |
| 2019 | $4.59 | $0.62 | $0.16 | $1.00 | $0.32 | $7.68 |
| 2020 | $4.69 | $1.45 | $0.33 | $0.97 | $0.32 | $8.98 |
| 2021 | $5.75 | $0.87 | $0.27 | $1.90 | $0.32 | $10.03 |
| 2022 | $6.74 | $1.66 | $0.27 | $1.71 | $0.32 | $10.86 |
| 2023 | $7.02 | $1.76 | $0.24 | $1.34 | $0.32 | $12.47 |
| 2024 | $7.21 | $1.05 | $0.39 | $1.47 | $0.32 | $13.08 |
| 2025 | $7.64 | $0.46 | $0.19 | $1.61 | $0.32 | $12.38 |
| 2026 | $7.74 | $1.16 | $0.18 | $1.68 | $0.32 | $13.51 |